Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients Undergoing Percutaneous Coronary Intervention Treated With the Glycoprotein IIb/IIIa Inhibitor Tirofiban
Military Medical Research - United Kingdom
doi 10.1186/s40779-016-0081-6
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 27, 2016
Authors
Publisher
Springer Science and Business Media LLC